Plain-English translation of NCT06665997 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether Depot Medroxyprogesterone Acetate (Depo-Provera), an injectable contraceptive, can help reduce the severe pain that women with sickle cell disease experience. Researchers want to understand if this medication can decrease how often and how badly these pain episodes happen. The study will track participants for 6 months total โ 3 months before receiving the injection and 3 months after.
Women with sickle cell disease often suffer from frequent, severe pain episodes that can require hospitalization. Doctors are exploring whether this medication might help manage that pain, which could improve quality of life and reduce the need for emergency care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the research clinic 6 to 7 times over 6 months for blood draws, urine pregnancy tests, and surveys about your health and pain. You would also complete weekly surveys from home and take monthly pregnancy tests at home. After a 3-month baseline period without hormonal birth control, you would receive one injection of the medication and then be monitored for an additional 3 months to see if your pain episodes improve.
AI-generated summary from trial data ยท Jun 9, 2026 ยท Not medical advice
United States